Patient info Open main menu

LADIVA - patient leaflet, side effects, dosage

Dostupné balení:

Patient leaflet - LADIVA

Package leaflet: Information for the patient

Raspberry Leaf dry extract

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Always take this medicine exactly as described in this leaflet or as your doctor, or pharmacist or qualified health care practitioner has told you.

  • – Keep this leaflet. You may need to read it again.

  • – Ask your pharmacist if you need more information or advice.

  • – If you get any side effects, talk to your doctor, or pharmacist or qualified health care practitioner. This includes any possible side effects not listed in this leaflet. See section 4.

  • – You must talk to a doctor if you do not feel better or if you feel worse after 7 days.

If symptoms persist during the use of the medicinal product or if adverse effect not mentioned in the package leaflet occur, a doctor should be consulted.

What is in this leaflet

  • 1. What Ladiva is and what it is used for

  • 2. What you need to know before you take Ladiva

  • 3. How to take Ladiva

  • 4. Possible side effects

  • 5. How to store Ladiva

  • 6. Contents of the pack and other information

1. what ladiva is and what it is used for

Ladiva contains Raspberry Leaf extract.

It is a traditional herbal medicinal product for the symptomatic relief of minor spasm associated with menstrual periods in adult females.

The product is a traditional herbal medicinal product for use in the specified indication exclusively based upon long-standing use.

You must talk to a doctor if you do not feel better or if you feel worse after 7 days.

2. what you need to know before you take ladiva-     if you are allergic to raspberry leaf extract or any of the other ingredients of this medicine

(listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before taking Ladiva.

Patients with renal and/or hepatic impairment:

Due to the lack of adequate data in these patient groups, a dose recommendation is not possible.

Children and adolescents

The use in children and adolescents under 18 years of age has not been established due to lack of adequate data.

Other medicines and Ladiva

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.

Medicinal products may affect each other if used simultaneously. No such interaction has been reported for Ladiva.

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Pregnancy

Safety during pregnancy has not been established. In the absence of sufficient data, the use during pregnancy is not recommended.

Breast-feeding

Safety during lactation has not been established. In the absence of sufficient data, the use during lactation is not recommended.

Fertility

Studies on the effect on fertility have not been performed.

Driving and using machines

No studies on the effect on the ability to drive and use machines have been performed.

3. how to take ladiva

Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Posology

Adult females:

The recommended dose is one capsule up to 3 to 4 times daily with water.

Patients with renal and/or hepatic impairment:

Due to the lack of adequate data in these patient groups, a dose recommendation is not possible.

Method of administration

Oral use.

Duration of use

If the symptoms persist longer than 7 days during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted.

Use in children and adolescents

The use in children and adolescents under 18 years has not been established due to lack of adequate data.

If you take more Ladiva than you should

If you take more Ladiva than you should, consult with your doctor, health care practitioner or pharmacist.

No case of overdose has been reported.

If you forget to take Ladiva

Do not take a double dose to make up for a forgotten dose. Continue to take your usual dose at the usual time.

4. possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

There is no known undesirable effect. If adverse reactions occur, a doctor or a qualified healthcare practitioner should be consulted.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly the Y ellow Card Scheme at: or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

5. how to store ladiva

Keep this medicine out of the sight and reach of children.

This medicine does not require any special storage conditions.

Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. contents of the pack and other informationthe active substance is raspberry leaf extract.

Each hard capsule contains 226 mg of extract (as dry extract) from Rubus idaeus L., folium (Raspberry Leaf) (3–5:1). Extraction solvent: water.

The other excipients are:

  • – capsule content: microcrystalline cellulose, talc, magnesium stearate, maize starch; silica, colloidal anhydrous

  • – capsule body: hypromellose, titanium dioxide (E171), iron oxide red (E172)

  • – capsule cap: hypromellose, titanium dioxide (E171), iron oxide yellow (E172)

What Ladiva looks like and contents of the pack

Ladiva are hard capsules with a beige cap and a light pink body filled with light brown powder.

Ladiva is available in a box with 1 or 2 PVC/PVDC-Al blisters.

Pack sizes: 8 or 16 capsules

Not all pack sizes may be marketed.

Traditional Herbal Registration Holder and Manufacturer

Traditional Herbal Registration Holder:

Medis GmbH

Europaring F15

2345 Brunn am Gebirge

Austria

Manufacturer:

Medis, d.o.o.

Brnciceva ulica 3

1231 Ljubljana-Cmuce

Slovenia

This medicinal product is registered in the Member States of the EEA under the following names:

Austria, Bulgaria, Czech Republic, Denmark, Finland, France, Germany, Croatia, Hungary, Norway, Poland, Slovakia, Slovenia, Spain, Sweden, United Kingdom: Ladiva

This leaflet was last revised in 03/2021

This leaflet is also available in large print, Braille or as an audio CD. To request a copy, please call 00

386 1 580 73 10 or email:

5